Epclusa Approved for Children With Any Hep C Genotype

FRIDAY, March 20, 2020 — Epclusa (sofosbuvir and velpatasvir) received approval for a supplemental application to treat hepatitis C virus (HCV) in children without cirrhosis or with mild cirrhosis, the U.S. Food and Drug Administration announced…
Source: Topamax